68Ga-NOTA Glu-Urea-Lys (NGUL) is a novel prostate-specific membrane antigen (PSMA)–
targeting tracer used for PET/CT imaging. This study aimed to compare performance in the …

Abstract Introduction [18F] PSMA-1007 has potential advantages over [68 Ga] Ga-PSMA-11,
although limited prospective data evaluating diagnostic performance exist. The aims of this …

Objective 68 Ga-NGUL is a novel prostate-specific membrane antigen (PSMA)-targeting
tracer based on Glu-Urea-Lys derivatives conjugated to a 1, 4, 7-triazacyclononane-N, N …

Purpose 68 Ga-PSMA-11 is a novel PET tracer suggested to be used for imaging of
advanced prostate cancer. In this study, we aimed to present a detailed biodistribution of 68 …

Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …

Introduction 68 Ga-PSMA (prostate specific membrane antigen) has increasingly used for
diagnosis in metastasis prostate cancer patients. This study aimed to evaluate the patient …

Purpose The aims of this retrospective analysis were to compare 68 Ga-PSMA PET findings
and low-dose CT findings (120 kV, 30 mA), and to obtain semiquantitative and quantitative …

Purpose Dual-time point PET/CT scanning with [68 Ga] Ga-PSMA-11 in the diagnosis of
prostate cancer (PC) has been advanced as a method to increase detection of PC lesions …

Abstract Background 68Ga-PSMA PET/CT has an important role in assessment of prostate
cancer patients with biochemical recurrence and is evolving in staging high-and …

PET/CT with 68 Ga-labeled prostate-specific membrane antigen (PSMA) is increasingly
recognized as the best imaging modality for disease staging and detection of recurrent …